Navigation Links
Class III Obese Patients Experience Adverse Events More Frequently Than the General Adverse Event Patient Population
Date:3/4/2013

g hospitals was developed to assess their practitioners' current knowledge about the use of opioids. More than 1,700 individual practitioners completed the assessment. The lowest-scoring questions encompassed topics identifying the predictors of respiratory depression in patients receiving intravenous opioids, defining what constitutes an opioid-tolerant patient, and choosing medications that could influence the effects of an opioid with respect to a patient's ventilation. Strategies that organizations may consider to improve education and to reduce medication errors associated with opioid use are included in this article, along with an educational toolkit.
  • Healthcare Outbreaks-Risk Assessment and Mitigation Based on Pathogen, Population and Environmental Factors: The P2E Concept: In 2009, Pennsylvania experienced one of the largest and most prolonged outbreaks of invasive group A streptococcus (GAS) within a nursing facility to date. The only known reservoirs for GAS in nature are the skin and mucous membranes of the human host. Therefore, one of the highest-risk patient populations is those who have nonintact skin. This article includes a novel framework describing proactive outbreak prevention based on pathogen, population and environment (P2E) risk assessment. Pennsylvania GAS outbreak facts are used as an example, and the framework is expanded to include carbapenem-resistant Enterobacteriaceae, demonstrating the framework's applicability to a multitude of outbreak scenarios.
  • Quarterly Update: What Body Parts and Procedures Are Associated with Wrong-Site Surgery?: This wrong-site surgery update discusses the lowest number of wrong-site surgeries (6) per quarter to date since reporting to the Authority began in mid-2004. Analysis of these events is provided, as well as an overview of the Au
    '/>"/>

SOURCE Pennsylvania Patient Safety Authority
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Affymax, Inc.
2. Intra-Cellular Therapies Announces Completion of Phase I Single Rising Dose Trial of First-in-Class Selective Phosphodiesterase 1 (PDE1) Inhibitor and Reports Top-line Safety and Pharmacokinetic Findings
3. Ferring Pharmaceuticals Inc. Recognized for Best-in-Class Work-Life Portfolio
4. Nelson Laboratories to Host Free Educational Device Testing Classes at 2013 MD&M West Show
5. The law firms of Bernstein Litowitz Berger & Grossmann LLP and Labaton Sucharow LLP announce pendency of class action in In re Schering-Plough Corporation / ENHANCE Securities Litigation
6. Details of HER-2/neu Class I Antigen Licensed by TapImmune published in Journal of Immunology: Antigen is a naturally processed epitope for breast cancer vaccines.
7. Robbins Arroyo LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Hemispherx Biopharma, Inc.
8. MAQUET Cardiovascular Announces U.S. Food and Drug Administration Panel Votes To Reclassify Intra-Aortic Balloon Pumps To A Class II Designation In Certain Indications
9. Barrack, Rodos & Bacine Files Class Action Lawsuit Against St. Jude Medical, Inc.
10. Thomson Reuters Empowers Drug Development and Clinical Professionals to Develop Better, Faster Clinical Trials with Best-in-Class Intelligence Solution
11. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- Researchers from the North American Menopause Society (NAMS) found ... too high, 1 putting women at risk for ... close to menopause are commonly told to take supplements ... as osteoporosis, to which they are particularly prone. ... calcium they typically get through their food sources before ...
(Date:7/23/2014)... 2014 This September leading clinicians in orthodontics ... Vegas for DOCtalk 2014 —a "Dynamic ... thinker and private practitioner Dr. David Sarver , ... discuss clinical and practice management efficiency and high quality ... opportunity to welcome fresh thinking and join a community ...
(Date:7/23/2014)... 2014 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) ... and research facility: Ampio Pharmaceuticals, 373 Inverness ... (720) 437-6500 Michael Macaluso , Ampio,s ... facility will be fully operational this summer, right ... Ampion TM necessary to accommodate the company,s BLA ...
Breaking Medicine Technology:Women Taking Too Much Calcium Create Health Risk 22014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2
... 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: ... a pharmaceutical company dedicated to improving healthcare through ... range of prescription and over-the-counter ("OTC") products, today ... Mr. Tony Liu and Chief Financial Officer, Ms. ...
... that a new market research report is available in ... in China http://www.reportlinker.com/p0363587/The-Top-10-CMOs-in-China.html ... and future outlook of CMO industry in China. It ... the top 10 CMOs. Other leading players are also ...
Cached Medicine Technology:American Oriental Bioengineering's CEO and CFO Visit the United States as Entrepreneur Representatives of President Hu Jintao's Delegation 2Reportlinker Adds The Top 10 CMOs in China 2
(Date:7/23/2014)... Adipic acid is an intermediate ... high-performance plastic, often referred to as engineering thermoplastics. ... on the monomers employed. Due to the high ... the increasing number of developing countries, the Asia-Pacific ... followed by Europe and North America. Adipic acid ...
(Date:7/23/2014)... News) -- Children and teens who lose a parent might ... a new study suggests. People who were children or ... risk of death during the study period than those who ... the report. Although the study found an association between ... death, it wasn,t designed to prove cause-and-effect. Also, the ...
(Date:7/23/2014)... at the emergency department, the drug ketamine can ... life-saving intubation, despite decades-old studies that suggested it ... systematic review of 10 recent studies of what ... are published online in Annals of Emergency ... Intracranial and Cerebral Perfusion Pressure and Health Outcomes: ...
(Date:7/23/2014)... 2014 SafeUseNow? , a ... developed by Principled Strategies , today announced ... California . Utilizing SafeUseNow’s patent-pending risk model, Partnership ... misusing and abusing controlled substance drugs, particularly prescription ... its members. , The agreement with Partnership HealthPlan ...
(Date:7/23/2014)... RFcnn.com, a distinguished electrical equipment retailer, has recently unveiled ... more, the company has decided to provide big price cuts ... an order for the company’s brand new SMA JACK can ... The high quality SMA JACK from RFcnn.com Provides a great ... electrical equipment to help make things much easier for worldwide ...
Breaking Medicine News(10 mins):Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Parent's Death May Raise Risk of Early Death for Grown Children, Study Suggests 2Health News:Ketamine can be a wonder drug for ER patients and their physicians 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 3Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 4Health News:New Collection of SMA JACK Released by China Electrical Accessory Manufacturer RFcnn 2
... GENEVA, Switzerland, December 15 Swiss-based, http://www.dnartistic.com ,s first ... million CHF and some of the proceeds will be ... of sister company, http://www.inneova.com . , ... Swiss scientist specialized in molecular,genetics of aging and co-founder ...
... Cross sheltered hundreds of people over the weekend who were affected ... Cross chapters opened shelters in Maine, Massachusetts, New Hampshire, New York ... ice storms are par for the course during the New England ... a safe and warm place to go when there are widespread ...
... VPHM ) today provided the following update regarding ... The Food and Drug Administration (FDA) has posted draft ... draft guidance is open for public comment, and if finalized ... the in vitro dissolution testing originally proposed in ...
... Dec. 15 Anthem Blue Cross and Blue Shield,(Anthem) ... life and health insurance organization, announced today that,Summerlin is ... for,its members and employer groups as it exits the ... an agreement that facilitates,the smooth transition of current Summerlin ...
... under age 65 were without health insurance for all or ... by the UCLA Center for Health Policy Research. ... California Health Interview Survey (CHIS), the policy brief,s authors found ... all or some of 2007, the most recent year for ...
... Education Virtual Lecture for Healthcare Professionals , ... Cytomegalovirus (CMV) infection is a serious condition and an ... hematopoietic stem cell transplant (HSCT) and solid organ transplant ... prevention. It is important for healthcare professionals working with ...
Cached Medicine News:Health News:DNA Jewel to Finance Anti-Aging Services & Cancer Research 2Health News:Red Cross Shelters Hundreds as Severe Weather Hits Northeast 2Health News:ViroPharma Provides Update on Vancocin(R) 2Health News:ViroPharma Provides Update on Vancocin(R) 3Health News:ViroPharma Provides Update on Vancocin(R) 4Health News:Anthem Blue Cross and Blue Shield and Summerlin Life and Health Insurance Company Enter Into Endorsement Agreement as Summerlin Announces Exit From the Commercial PPO Business in Nevada 2Health News:Anthem Blue Cross and Blue Shield and Summerlin Life and Health Insurance Company Enter Into Endorsement Agreement as Summerlin Announces Exit From the Commercial PPO Business in Nevada 3Health News:Nearly 6.4 million Californians lack health insurance, report shows 2Health News:CMV Infection in Transplant Recipients: Clinical Cases and Expert Opinion 2
... The Isoseeds I-125 are brachytherapy sources ... treatment of localized tumors, especially in the ... after the conclusion of the therapeutic effect, ... I-125 are intended for single use. They ...
Mirror prismatic gonioscope. Titanium body....
Four 62 mirrors give a 360 view of the anterior chamber angle with only a slight lens rotation. Posterior pole can be viewed through center of lens....
... mirrors allow complete observation ... little lens rotation. Small ... for eyes with small ... ring available in small ...
Medicine Products: